Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
13.59
-0.23 (-1.66%)
May 15, 2026, 4:00 PM EDT - Market closed
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $1.19 billion as of May 18, 2026. Its market cap has increased by 228.25% in one year.
Market Cap
1.19B
Enterprise Value
685.66M
1-Year Change
228.25%
Ranking
Category
Stock Price
$13.59
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $1.19B, a decrease of -33.85%. That is a compound annual growth rate of -7.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.19B | -39.64% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 1.29B |
| MoonLake Immunotherapeutics | 1.28B |
| Savara | 1.28B |
| AbCellera Biologics | 1.25B |
| Avalyn Pharma | 1.25B |
| Hemab Therapeutics Holdings | 1.24B |
| Septerna | 1.21B |
| DBV Technologies | 1.17B |